Haritma Nigam¹*, Karan Thakkar², Hani Yousuf Naik³, Heram Singh³, Saurav Kumar⁴, Rafiya Raheel⁵, Rashi Bansal⁶ and Mahboob Hoda³

¹1Associate Professor, Department of Oral Medicine and Radiology, Pacific Dental College and Research Centre, Udaipur, India
²Intern, Oral Medicine and Radiology, Department of Pacific Dental College and Research Centre, Udaipur, India
³Assistant Professor, Department of Oral and Maxillofacial Surgery, Pacific Dental College and Research Centre, Udaipur, India
⁴Department Of Oral and Maxillofacial Surgery, Private Practioner, Ranchi, Jharkhand, India
⁵Assistant Professor and GP Dentist, Department of Oral Medicine and Radiology, Rakcods, UAE
⁶Intern, Department of Oral Medicine and Radiology, Pacific Dental College and Research Centre, Udaipur, India

*Corresponding Author: Haritma Nigam, Associate Professor, Department of Oral Medicine and Radiology, Pacific Dental College and Research Centre, Udaipur, India.

Received: January 23, 2023; Published: February 07, 2023

Abstract

The Lassa fever (Haemorrhagic, zoonotic disease) was founded in the town Lassa, Nigeria in 1969th, which is transmitted by rodents. It is an endemic disease located in West Africa. Nosocomial transmission is most common where there is inadequate supply of proper equipments. 80% people with Lassa virus are asymptomatic with an incubation period of 6-12 days. Having diverse symptoms the diagnosis of Lassa fever becomes difficult however clinical features and confirmed laboratory test makes diagnosis of Lassa fever possible. Antiviral drugs can be the mode of treatment for the same.

Keywords: Haemorrhagic Fever; Lassa Fever; Nosocomial Infection; West Africa; Zoonotic Disease

References

1. World health organization World Health Organization. “Lassa fever in Nigeria. Emergencies Preparedness, Response Disease Outbreak News (DONs) (2017).
2. Kumar and Clark's Clinical Medicine,10^th Edition, Elsevier (2020).
3. Centers for disease control and prevention (2015) Lassa fever (2015).
4. Nigeria centre for disease control. Lassa fever situation report (2020).
5. Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review (2021).
6. John-Ugwuanya A., et al. “Lassa fever and COVID-19 in Africa: a double crisis on the fragile health system”. Journal of Medical Virology 10 (2021):5707.
7. Reuben RC., et al. “Co-epidemics: have measure against COVID-19 helped to reduce Lassa fever cases in Nigeria?” New Microbes and New Infections 40(2021):100851.
8. Abbas Abel Anzaku. “Current Trends of Lassa fever Outbreak in Nigeria; A Call for Global Response”. Journal of AIDS and HIV Research 2 (2018):1.
9. McCarthy M. “USA moves quickly to push biodefence research”. Lancet 360 (2002):732.
10. , et al. “Infection pattern, case fatality rate and spread of lassa virus in Nigeria”. BMC Infectious Diseases 21.1 (2021)1-9.
11. Akhiwu HO., et al. “Lasaa fever outbreak in adolescents in north central nigeria: report of cases”. Journal of Virus Eradication 4 (2018): 225-227.
12. Nigeria centere for Disease control. An update of Lassa fever outbreak in Nigeria (2021).
13. Mofolorunsho KC. “Outbreak of Lassa fever in nigeria: measures for prevention and control”. The Pan African Medical Journal 23 (2016): 210.
14. Inegbenebor U., et al. “Prevention of Lassa fever in Nigeria”. Royal Society of Tropical Medicine and Hygiene 104 (2009): 51-54.
15. Ilori EA., et al. “Epidemiologic and clinical features of lassa fever outbreak in nigeria, January 1- may 6, 2018”. Emerging Infectious Diseases 25 (2019): 1066-1074.
16. Okogbenin EO., et al. “One-year retrospective review of psychiatric consultations in Lassa fever, southern Nigeria”. Emerging Infectious Diseases 26 (2020): 3091-3093.
17. Okokhere P., et al. “Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: an observational cohort study”. Lancet Infectious Diseases 18 ():684-695.
18. Harrison's Principles of Internal Medicine, 20^th Edition, Elsevier 1 (2018).

Citation

Citation: Haritma Nigam., et al. “The Lassa Fever-A Threat in Covid-19".Acta Scientific Dental Sciences 7.3 (2023): 21-25.

Copyright

Copyright: © 2023 Haritma Nigam., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.